TRANSCEND FL: Phase 2 study results of lisocabtagene maraleucel (liso-cel) in patients (pts) with relapsed/refractory (R/R) follicular lymphoma (FL) Meeting Abstract


Authors: Borchmann, P.; Morschhauser, F.; Dahiya, S.; Palomba, M. L.; García-Sancho, A. M.; Ortega, J. L. R.; Kuruvilla, J.; Jäger, U.; Cartron, G.; Izutsu, K.; Dreyling, M.; Kahl, B.; Ghesquieres, H.; Ardeshna, K.; Goto, H.; Barbui, A. M.; Abramson, J. S.; Fleury, I.; Mielke, S.; Farazi, T.; Fasan, O.; Lymp, J.; Vedal, M.; Nishii, R.; Avilion, A.; Papuga, J.; Nastoupil, L. J.
Abstract Title: TRANSCEND FL: Phase 2 study results of lisocabtagene maraleucel (liso-cel) in patients (pts) with relapsed/refractory (R/R) follicular lymphoma (FL)
Meeting Title: 36. Deutscher Krebskongress - Fortschritt gemeinsam gestalten
Journal Title: Oncology Research and Treatment
Volume: 47
Issue: Suppl. 1
Meeting Dates: 2024 Feb 21-24
Meeting Location: Berlin, Germany
ISSN: 2296-5270
Publisher: S. Karger AG  
Date Published: 2024-02-01
Start Page: 142
End Page: 143
Language: English
ACCESSION: WOS:001332646400336
PROVIDER: wos
DOI: 10.1159/000535363
Notes: Meeting Abstract: 262 -- 'The 36th German Cancer Congress - Building Progress Together' -- Located in the section 'Novel Therapeutics: Targeted Therapies, Immunotherapies, Cellular Therapies' -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Maria Lia Palomba
    415 Palomba